Dhiraj Yadav MD

Assistant Professor, Medicine, University of Pittsburgh School of Medicine

Education & Training

New York Medical College at St Vincent's Hospital and Medical Center of New YorkFellowship, Gastroenterology, 1998 - 2001
Westchester Medical CenterResidency, Internal Medicine, 1995 - 1998
Jawaharlal Nehru Medical CollegeClass of 1993

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

PubMed

2 citations
Multiparametric MRI Scoring System of the Pancreas for the Diagnosis of Chronic Pancreatitis.
Temel Tirkes, Dhiraj Yadav, Darwin L Conwell, Xuandong Zhao, Anil K Dasyam
Journal of Magnetic Resonance Imaging. 2025-05-01
Endoscopic and Surgical Treatments for Painful Chronic Pancreatitis: A Scoping Review of Pain Assessment Tools and Meta-analysis of Outcomes.
Mahya Faghih, Mitchell L Ramsey, Misbah Unnisa, Anna E Phillips, Katie Lobner
Pancreas. 2025-04-07
Health Inequities in Pancreatic Disorders in the Black/African American Community.
Radmila Choate, Darwin L Conwell, Rachel L Hill, Alyce Sophia Adams, Dhiraj Yadav
Journal of Racial and Ethnic Health Disparities. 2025-03-26

Journal Articles

Response to Hao Et Al
Dhiraj Yadav, Timothy B Gardner, Gregory A Cote, Nature
Influence of Ambulatory Triglyceride Levels on Risk of Recurrence in Patients with Hypertriglyceridemic Pancreatitis
Dhiraj Yadav, MD, Digestive Diseases and Sciences
Hereditary Pancreatitis in the United States: Survival and Rates of Pancreatic Cancer
Chandraprakash Umapathy, David C Whitcomb, Dhiraj Yadav, Nature
Recurrent Acute Pancreatitis Significantly Reduces Quality of Life Even in the Absence of Overt Chronic Pancreatitis
Dhiraj Yadav, Bimaljit S Sandhu, Nalini M Guda, Vikesh K Singh, John Baillie, Randall Brand, Andres Gelrud, David C Whitcomb, Darwin Conwell, Stuart Sherman, Adam Sliv..., Nature
Join now to see all

What Are the Warning Signs of Pancreatitis?June 8th, 2022
Cedars-Sinai Awarded $10 Million to Study Pancreatic DiseasesSeptember 25th, 2019
Diagnosis of Autoimmune Pancreatitis: The Evolution of Diagnostic Criteria for a Rare DiseaseJune 17th, 2017
Join now to see all

Parallel-group randomized controlled trial of Pioglitazone versus empagliflozin for T3cDM: The PEP-DM TrialMAYO CLINIC ROCHESTER2024–2027
Parallel-group randomized controlled trial of Pioglitazone versus empagliflozin for T3cDM: The PEP-DM TrialMAYO CLINIC ROCHESTER2024–2027
SpHincterotomy for Acute Recurrent PancreatitisOREGON HEALTH & SCIENCE UNIVERSITY2021–2025
SpHincterotomy for Acute Recurrent PancreatitisOREGON HEALTH & SCIENCE UNIVERSITY2021–2025
SpHincterotomy for Acute Recurrent PancreatitisOREGON HEALTH & SCIENCE UNIVERSITY2021–2025
UPMC Clinical Center for the Study of Diabetes After Acute PancreatitisUNIVERSITY OF PITTSBURGH AT PITTSBURGH2020–2025
UPMC Clinical Center for the Study of Diabetes After Acute PancreatitisUNIVERSITY OF PITTSBURGH AT PITTSBURGH2020–2025
Consortium for the Study of Pancreatitis: Pittsburgh Clinical CenterUNIVERSITY OF PITTSBURGH AT PITTSBURGH2015–2025
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical CenterUNIVERSITY OF PITTSBURGH AT PITTSBURGH2015–2025
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical CenterUNIVERSITY OF PITTSBURGH AT PITTSBURGH2015–2025
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical CenterUNIVERSITY OF PITTSBURGH AT PITTSBURGH2015–2025